Patents by Inventor Mark Wechser

Mark Wechser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Classification of Patients Having Diffuse Large B-cell Lymphoma Based upon Gene Expression
    Publication number: 20100143926
    Abstract: Methods and kits for classifying patients having diffuse large B-cell lymphoma (DLBCL) based upon expression of a plurality of genes are disclosed. Real-time quantitative RT-PCR can be used to measure expression values. Correlating expression values of the plurality of genes in a tumor sample from the patient to reference expression values obtained from DLBCL patients can stratify patients in the classification groups. The methods and kits can be used to predict overall patient survival.
    Type: Application
    Filed: November 24, 2009
    Publication date: June 10, 2010
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Ronald Levy, Mark A. Wechser, Izidore S. Lossos, Robert J. Tibshirani, Ash A. Alizadeh, David Botstein
  • Classification of patients having diffuse large b-cell lymphoma based upon gene expression
    Patent number: 7622253
    Abstract: Methods and kits for classifying patients having diffuse large B-cell lymphoma (DLBCL) based upon expression of a plurality of genes are disclosed. Real-time quantitative RT-PCR can be used to measure expression values. Correlating expression values of the plurality of genes in a tumor sample from the patient to reference expression values obtained from DLBCL patients can stratify patients in the classification groups. The methods and kits can be used to predict overall patient survival.
    Type: Grant
    Filed: October 3, 2006
    Date of Patent: November 24, 2009
    Inventors: Ronald Levy, Mark A. Wechser, Izidore S. Lossos, Robert J. Tibshirani, Ash A. Alizadeh, David Botstein
  • Classification of patients having diffuse large B-cell lymphoma based upon gene expression
    Patent number: 7332280
    Abstract: Methods and kits for classifying patients having diffuse large B-cell lymphoma (DLBCL) based upon expression of a plurality of genes are disclosed. Real-time quantitative RT-PCR can be used to measure expression values. Correlating expression values of the plurality of genes in a tumor sample from the patient to reference expression values obtained from DLBCL patients can stratify patients in the classification groups. The methods and kits can be used to predict overall patient survival.
    Type: Grant
    Filed: March 3, 2004
    Date of Patent: February 19, 2008
    Inventors: Ronald Levy, Mark A. Wechser, Izidore S. Lossos, Robert J. Tibshirani, Ash A. Alizadeh, David Botstein
  • Classification of patients having diffuse large B-cell lymphoma based upon gene expresson
    Publication number: 20070026453
    Abstract: Methods and kits for classifying patients having diffuse large B-cell lymphoma (DLBCL) based upon expression of a plurality of genes are disclosed. Real-time quantitative RT-PCR can be used to measure expression values. Correlating expression values of the plurality of genes in a tumor sample from the patient to reference expression values obtained from DLBCL patients can stratify patients in the classification groups. The methods and kits can be used to predict overall patient survival.
    Type: Application
    Filed: October 3, 2006
    Publication date: February 1, 2007
    Inventors: Ronald Levy, Mark Wechser, Izidore Lossos, Robert Tibshirani, Ash Alizadeh, David Botstein
  • Classification of patients having diffuse large B-cell lymphoma based upon gene expression
    Publication number: 20050079513
    Abstract: Methods and kits for classifying patients having diffuse large B-cell lymphoma (DLBCL) based upon expression of a plurality of genes are disclosed. Real-time quantitative RT-PCR can be used to measure expression values. Correlating expression values of the plurality of genes in a tumor sample from the patient to reference expression values obtained from DLBCL patients can stratify patients in the classification groups. The methods and kits can be used to predict overall patient survival.
    Type: Application
    Filed: March 3, 2004
    Publication date: April 14, 2005
    Inventors: Ronald Levy, Mark Wechser, Izidore Lossos, Robert Tibshirani, Ash Alizadeh, David Botstein